Order Article Reprints

Marino AG, Cambise N, De Benedetto F, Lenci L, Pontecorvo S, Di Perna F, Buonamassa G, Belmusto A, Tremamunno S, De Vita A, et al. Metoprolol vs. Diltiazem in Patients with Angina and Non-Obstructive Coronary Artery Disease with or Without Evidence of Coronary Microvascular Spasm on Acetylcholine Testing. Journal of Clinical Medicine. 2025; 14(21):7635. https://doi.org/10.3390/jcm14217635

Marino, Angelo Giuseppe, Nello Cambise, Fabio De Benedetto, Ludovica Lenci, Sara Pontecorvo, Federico Di Perna, Giacomo Buonamassa, Antonietta Belmusto, Saverio Tremamunno, Antonio De Vita, and et al. 2025. "Metoprolol vs. Diltiazem in Patients with Angina and Non-Obstructive Coronary Artery Disease with or Without Evidence of Coronary Microvascular Spasm on Acetylcholine Testing" Journal of Clinical Medicine 14, no. 21: 7635. https://doi.org/10.3390/jcm14217635

Marino, A. G., Cambise, N., De Benedetto, F., Lenci, L., Pontecorvo, S., Di Perna, F., Buonamassa, G., Belmusto, A., Tremamunno, S., De Vita, A., Capasso, R., Montone, R. A., & Lanza, G. A. (2025). Metoprolol vs. Diltiazem in Patients with Angina and Non-Obstructive Coronary Artery Disease with or Without Evidence of Coronary Microvascular Spasm on Acetylcholine Testing. Journal of Clinical Medicine, 14(21), 7635. https://doi.org/10.3390/jcm14217635